TY - JOUR
AU - J. Nealon
AU - D. Modin
AU - R. Ghosh
AU - D. Rudin
AU - G. Gislason
AU - H. Booth
AU - J. Jensen
AU - R. Williams
AU - H. Shepherd
AU - E. Yelland
AU - H. Bricout
AU - S. Chaves
AU - T. Biering-Sørensen
AD - Sanofi Pasteur Medical Evidence Generation, Lyon, France. jnealon@hku.hk.
School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, Pokfulam, China. jnealon@hku.hk.
Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK.
Sanofi Pasteur Global Medical Affairs, Swiftwater, PA, USA.
Department of Pulmonology, Copenhagen University Hospital-Herlev and Gentofte & Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Sanofi Pasteur Medical Evidence Generation, Lyon, France.
Modelling, Epidemiology and Data Science, Sanofi Pasteur, Lyon, France.
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
AN - 35197469
BT - NPJ Vaccines
DO - 10.1038/s41541-022-00444-6
DP - NLM
ET - 2022/02/25
LA - eng
M1 - 1
N1 - 2059-0105
Nealon, Joshua
Orcid: 0000-0003-1538-4636
Modin, Daniel
Ghosh, Rebecca E
Orcid: 0000-0001-6009-3040
Rudin, Deborah
Gislason, Gunnar
Booth, Helen P
Jensen, Jens Ulrik Stæhr
Williams, Rachael
Shepherd, Hilary
Orcid: 0000-0001-7794-4155
Yelland, Eleanor
Bricout, Helene
Chaves, Sandra S
Orcid: 0000-0002-9453-7057
Biering-Sørensen, Tor
Journal Article
England
NPJ Vaccines. 2022 Feb 23;7(1):25. doi: 10.1038/s41541-022-00444-6.
PY - 2022
SN - 2059-0105
EP - 25
T2 - NPJ Vaccines
TI - The feasibility of pragmatic influenza vaccine randomized controlled real-world trials in Denmark and England
VL - 7
ER -